ASPN and cystic fibrosis: Knockdown of either SOX9 and ASPN in CF via siRNA resulted in significantly decreased expression of active β-catenin in these cells (Figure 5J), indicating that Sox9 and Aspn may promote CF-to-MF and CF-to-OF by upregulating β-catenin in CF.